MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson’s disease- First case series from Middle-East Region

    S. Mittal, A. Aldakheel, W. Mohammed, T. Alkhairallah, B. Klassen, M. Thomas, T. Maiti, S. Wasti (Abu Dhabi, United Arab Emirates)

    Objective: The objective is to report unique and challenging cases, who had successful control of Parkinson’s disease (PD) symptoms with combination therapy of Deep Brain…
  • 2022 International Congress

    Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

    Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial

    HJ. Chang, J. Park, S. Oh, CW. Shin, JW. Cho, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to assess the efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease (PD) patients with motor fluctuation. Background: Delayed…
  • 2022 International Congress

    The clinical challenge of an unilateral abnormal uptake in datscan

    C. Silva, F. Barros, F. Matias, CM. Machado, FM. Moreira, M. Cunha, A. Morgadinho (Coimbra, Portugal)

    Objective: Characterize patients with unilateral abnormal uptake in DaTscan. Background: Presynaptic dopamine transporter (DaT) single-photon emission computed tomography (SPECT) imaging is the most used imaging…
  • 2022 International Congress

    Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

    Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…
  • 2022 International Congress

    Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present the case of a woman with Parkinson’s disease (PD) who developed pemphigoid-like skin lesions after being started on safinamide therapy. Background: Safinamide…
  • 2022 International Congress

    A randomized controlled trial comparing the efficacy and safety of pyridostigmine versus midodrine for the treatment of orthostatic hypotension in Parkinson’s disease patients

    C. Limwatthana (Bangkok, Thailand)

    Objective: To assess the long-term efficacy and safety of pyridostigmine and midodrine in the treatment of OH in PD. Background: In  Parkinson's  disease  (PD),  orthostatic…
  • 2022 International Congress

    Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson´s Disease: An Open-label Prospective Study

    D. Santos García, G. Fernández Pajarín, J. Oropesa Ruíz, F. Escamilla Sevilla, R. Rahim Lopez, G. Muñoz Enríquez (A Coruña, Spain)

    Objective: The aim of this study was to analyze the effectiveness of opicapone on global non-motor symptoms (NMS) burden in Parkinson´s disease (PD). Background: Some…
  • 2022 International Congress

    Test-Retest Reliability of the PDQ-Carer

    D. Morley, S. Dummett, D. Churchman, L. Kelly, C. Jenkinson (Oxford, United Kingdom)

    Objective: To assess the test-retest reliability of the PDQ-Carer health related quality of life measure. Background: The PDQ-Carer is a 29-item measure of health related…
  • 2022 International Congress

    Clinical and risk profiles of Parkinson’s disease from a large pan-India cohort: interim observations of the GAP-India study

    A. Kishore, R. Borgohain, R. Rajan, K. Divya, L. Prashanth, P. Pal, S. Mehta, H. Kumar, N. Kumar, S. Desai, R. Kamdadai, S. Krishnan, M. Chacko, M. Sharma (Kochi, India)

    Objective: To create a pan-Indian clinical repository of Parkinson’s Disease (PD). Background: The genetic risk for PD in India is unknown. The Luxembourg-German India Alliance…
  • « Previous Page
  • 1
  • …
  • 303
  • 304
  • 305
  • 306
  • 307
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley